Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check6 days agoChange DetectedThe page lost the condition tag 'Schizophrenia' and the related topics entry for 'MedlinePlus Genetics', and the related topics section appears removed, reducing cross-links but not altering the main trial details.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics to the page's related topics.SummaryDifference0.1%

- Check35 days agoChange DetectedThe 'Schizophrenia' condition label and the 'MedlinePlus Genetics' related topics section were removed from the page. This reduces key contextual cues about the study's condition and related resources.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study details page.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.